| Literature DB >> 20433142 |
Anna Kovalová1, Miroslav Ledvina, David Saman, Daniel Zyka, Monika Kubícková, Lukás Zídek, Vladimír Sklenár, Petr Pompach, Daniel Kavan, Jan Bílý, Ondrej Vanek, Zuzana Kubínková, Martina Libigerová, Ljubina Ivanová, Mária Antolíková, Hynek Mrázek, Daniel Rozbeský, Katerina Hofbauerová, Vladimír Kren, Karel Bezouska.
Abstract
On the basis of the highly branched ovomucoid-type undecasaccharide that had been shown previously to be an endogenous ligand for CD69 leukocyte receptor, a systematic investigation of smaller oligosaccharide mimetics was performed based on linear and branched N-acetyl-d-hexosamine homooligomers prepared synthetically using hitherto unexplored reaction schemes. The systematic structure-activity studies revealed the tetrasaccharide GlcNAcbeta1-3(GlcNAcbeta1-4)(GlcNAcbeta1-6)GlcNAc (compound 52) and its alpha-benzyl derivative 49 as the best ligand for CD69 with IC(50) as high as 10(-9) M. This compound thus approaches the affinity of the classical high-affinity neoglycoprotein ligand GlcNAc(23)BSA. Compound 68, GlcNAc tetrasaccharide 52 dimerized through a hydrophilic flexible linker, turned out to be effective in activating CD69(+) lymphocytes. It also proved efficient in enhancing natural killing in vitro, decreasing the growth of tumors in vivo, and activating the CD69(+) tumor infiltrating lymphocytes examined ex vivo. This compound is thus a candidate for carbohydrate-based immunomodulators with promising antitumor potential.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20433142 DOI: 10.1021/jm100055b
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446